Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
Journal
Frontiers in medicine
Journal Volume
10
Date Issued
2023
Author(s)
Chang, Cheng-Yu
Wei, Yu-Feng
Lai, Yi-Chun
Hu, Po-Wei
Hung, Jui-Chi
Chu, Chi-Hsiang
Chuang, Hsin-Tzu
Chang, Shih-Chieh
Abstract
Randomized controlled trials have demonstrated a reduction in the decline of lung function and a reduced risk of acute exacerbation in patients with idiopathic pulmonary fibrosis treated with the antifibrotic prifenidone. The present study aimed to investigate the real-world effectiveness and safety profile of pirfenidone treatment for patients with IPF in Taiwan.
Subjects
forced vital capacity; idiopathic pulmonary fibrosis; pirfenidone; progression free survival; tumor necrosis factor alpha
Type
journal article